ArticleProceedings of the National Academy of Sciences of the United States of America2024

Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.

Christopher Roselle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.